Daniel D’Almeida Preto

633 total citations
21 papers, 88 citations indexed

About

Daniel D’Almeida Preto is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Daniel D’Almeida Preto has authored 21 papers receiving a total of 88 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Daniel D’Almeida Preto's work include Palliative Care and End-of-Life Issues (6 papers), Prostate Cancer Treatment and Research (4 papers) and Cancer Diagnosis and Treatment (3 papers). Daniel D’Almeida Preto is often cited by papers focused on Palliative Care and End-of-Life Issues (6 papers), Prostate Cancer Treatment and Research (4 papers) and Cancer Diagnosis and Treatment (3 papers). Daniel D’Almeida Preto collaborates with scholars based in Brazil, United States and United Kingdom. Daniel D’Almeida Preto's co-authors include Carlos Eduardo Paiva, Bianca Sakamoto Ribeiro Paiva, Donald C. McMillan, Cleyton Zanardo de Oliveira, Yara Cristina de Paiva Maia, Éduardo Bruera, David Hui, Barry Laird, Ross D. Dolan and Josh McGovern and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and British Journal Of Nutrition.

In The Last Decade

Daniel D’Almeida Preto

18 papers receiving 87 citations

Peers

Daniel D’Almeida Preto

ONCOL

PHEOH

SURGE

PRM

Ana Patricia Alcasabas Philippines

Tony Philip United States

Atalel Fentahun Awedew Ethiopia

Arantza López de Munain Spain

Ana Ávila Bernabéu Spain

Danielle Riley United States

Mohammad Ghannam Palestinian Territory

Thierry Muron France

A Elbasmi Kuwait

Thakshayeni Skanthakumar Singapore

Ana Patricia Alcasabas Philippines

Daniel D’Almeida Preto

30 ×0.7

ONCOL

23 ×0.8

PHEOH

12 ×0.6

SURGE

38 ×2.4

PRM

10 ×0.9

Citations per year, relative to Daniel D’Almeida Preto Daniel D’Almeida Preto (= 1×) peers Ana Patricia Alcasabas

Countries citing papers authored by Daniel D’Almeida Preto

Since Specialization

Citations

This map shows the geographic impact of Daniel D’Almeida Preto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel D’Almeida Preto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel D’Almeida Preto more than expected).

Fields of papers citing papers by Daniel D’Almeida Preto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel D’Almeida Preto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel D’Almeida Preto. The network helps show where Daniel D’Almeida Preto may publish in the future.

Co-authorship network of co-authors of Daniel D’Almeida Preto

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel D’Almeida Preto. A scholar is included among the top collaborators of Daniel D’Almeida Preto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel D’Almeida Preto. Daniel D’Almeida Preto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maluf, Fernando Cotait, Karine Martins da Trindade, Daniel D’Almeida Preto, et al.. (2025). Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With Advanced Penile Cancer. JAMA Oncology. 11(11). 1314–1314.

McGovern, Josh, Carlos Eduardo Paiva, Ross D. Dolan, et al.. (2025). Prognostic value of the Global Leadership Initiative on Malnutrition criteria including systemic inflammation in patients with advanced cancer. British Journal Of Nutrition. 133(2). 246–252.

Preto, Daniel D’Almeida, Gustavo Nóriz Berardinelli, Vinícius Duval da Silva, et al.. (2024). PD-L1 expression and microsatellite instability (MSI) in cancer of unknown primary site. International Journal of Clinical Oncology. 29(6). 726–734. 2 indexed citations

Maluf, Fernando Cotait, Karine Martins da Trindade, Daniel D’Almeida Preto, et al.. (2024). A phase II trial of pembrolizumab plus platinum-based chemotherapy as first-line systemic therapy in advanced penile cancer: HERCULES (LACOG 0218) trial.. Journal of Clinical Oncology. 42(16_suppl). 5009–5009. 11 indexed citations

Paiva, Carlos Eduardo, et al.. (2023). To Treat or Not to Treat? Dilemmas when Deciding on Antineoplastic Treatment in Patients With Far Advanced Cancers. Cancer Control. 30. 2915594687–2915594687. 3 indexed citations

Sandhu, Shahneen, Geoffrey Gotto, Francisco Vera-Badillo, et al.. (2023). 1835P A prospective study to determine the prevalence of DNA repair defects in patients (pts) with advanced prostate cancer (PC). Annals of Oncology. 34. S993–S993. 2 indexed citations

Paiva, Carlos Eduardo, et al.. (2023). Discrepancies in breast cancer’s oncological outcomes between public and private institutions in the southeast region of Brazil: a retrospective cohort study. Frontiers in Oncology. 13. 1169982–1169982. 2 indexed citations

Maluf, Fernando Cotait, Karine Martins da Trindade, Daniel D’Almeida Preto, et al.. (2023). A phase II trial of pembrolizumab combined with platinum-based chemotherapy as first-line systemic therapy in advanced penile cancer: HERCULES (LACOG 0218) trial.. Journal of Clinical Oncology. 41(6_suppl). TPS14–TPS14. 4 indexed citations

Paiva, Carlos Eduardo, Miguel Julião, Daniel D’Almeida Preto, et al.. (2022). Comprehension and Decision-Making Capacity Questionnaire About Palliative Care and Advance Care Planning: A Delphi Study. Journal of Palliative Care. 38(1). 41–51. 3 indexed citations

10.

Preto, Daniel D’Almeida, Bianca Sakamoto Ribeiro Paiva, David Hui, Éduardo Bruera, & Carlos Eduardo Paiva. (2022). HAprog: A New Prognostic Application to Assist Oncologists in Routine Care. Journal of Pain and Symptom Management. 63(6). 1014–1021.e4. 2 indexed citations

11.

Dolan, Ross D., Carlos Eduardo Paiva, Josh McGovern, et al.. (2022). Inflammation and Performance Status: The Cornerstones of Prognosis in Advanced Cancer. Journal of Pain and Symptom Management. 65(4). 348–357. 14 indexed citations

12.

Berardinelli, Gustavo Nóriz, Daniel D’Almeida Preto, Vinícius Duval da Silva, et al.. (2022). PD-L1 expression and microsatellite instability in tumors of unknown primary site.. Journal of Clinical Oncology. 40(16_suppl). 2635–2635. 1 indexed citations

13.

Dionísio, Maria Rita, André Filipe Vieira, Rita Carvalho, et al.. (2020). BR-BCSC Signature: The Cancer Stem Cell Profile Enriched in Brain Metastases that Predicts a Worse Prognosis in Lymph Node-Positive Breast Cancer. Cells. 9(11). 2442–2442. 13 indexed citations

14.

Preto, Daniel D’Almeida, et al.. (2020). Extension of bone marrow involvement and cytopenias in patients with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 38(6_suppl). 222–222. 1 indexed citations

15.

Zucca, Luis Eduardo Rosa, et al.. (2020). Real-world outcome with abiraterone low-dose plus prednisone in patients with mCRPC in a Brazilian Public Cancer Center.. Journal of Clinical Oncology. 38(15_suppl). e17563–e17563. 1 indexed citations

16.

Preto, Daniel D’Almeida, Marco Antônio de Oliveira, Gustavo Dix Junqueira Pinto, et al.. (2019). Impact of AferBio® on quality of life and chemotherapy toxicity in advanced lung cancer patients (AFERBIO study): protocol study for a phase II randomized controlled trial. BMC Cancer. 19(1). 382–382. 1 indexed citations

17.

Ferrari, Michael, et al.. (2019). Estudo clínico e epidemiológico das anemias em pacientes hospitalizados. Revista de Medicina. 98(1). 23–29.

18.

Preto, Daniel D’Almeida, et al.. (2019). Clinical Prediction of Survival in Advanced Cancer Outpatients: Do Experienced Physicians and With Prior Patient Evaluation Make More Accurate Predictions?. Journal of Pain and Symptom Management. 59(1). e7–e10. 2 indexed citations

19.

Paiva, Carlos Eduardo, Bianca Sakamoto Ribeiro Paiva, Daniel D’Almeida Preto, et al.. (2018). Development and validation of a prognostic nomogram for ambulatory patients with advanced cancer. Cancer Medicine. 7(7). 3003–3010. 13 indexed citations

20.

Cerci, Juliano J., Evelinda Trindade, Rodrigo Cerci, et al.. (2014). Investigation Route of the Coronary Patient in the Public Health System in Curitiba, São Paulo and in Incor - IMPACT Study. Arquivos Brasileiros de Cardiologia. 103(3). 192–200. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact